Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - perindopril arginine, indapamide - film coated tablet - 10/2.5 - ace inhibitors and diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - perindopril arginine, indapamide - film coated tablet - 10/2.5 - ace inhibitors and diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - indapamide; perindopril arginine - film-coated tablet - 10/2.5 milligram(s) - ace inhibitors and diuretics; perindopril and diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril arginine; indapamide - film-coated tablet - 10 mg/2.5 milligram(s) - ace inhibitors and diuretics; perindopril and diuretics

Malta - English - Medicines Authority

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - perindopril arginine, indapamide - film-coated tablet - indapamide 2.5 mg perindopril arginine 10 mg - agents acting on the renin-angiotensin system

Ireland - English - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril tert-butylamine, indapamide - tablets - 8/2.5 mg/mg - ace inhibitors and diuretics

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - populus deltoides subsp. monilifera pollen (unii: 5928lj1441) (populus deltoides subsp. monilifera pollen - unii:5928lj1441) - populus deltoides subsp. monilifera pollen 10000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

India - English - Central Drugs Standard Control Organization

ipca - methotrexate - tab - 10mg - 10

India - English - Central Drugs Standard Control Organization

ipca - methotrexate - tab - 15mg - 10

India - English - Central Drugs Standard Control Organization

ipca - methotrexate - tab - 2.5mg - 10